OKLAHOMA CITY (June 2, 2023) - Oklahoma Attorney General Gentner Drummond, Wisconsin Attorney General Josh Kaul and 40 other U.S. attorneys general have negotiated a $102.5 million settlement with the maker of Suboxone, a prescription medication used to treat opioid addiction. Oklahoma will receive approximately $1.27 million from the settlement against the pharmaceutical company, Indivior Inc.
You are here
Newsroom
Newsroom
Media Contacts
Phil Bacharach, Communications Director
Office: 405-522-3116
Email: [email protected]
Leslie Berger, Press Secretary
Office: 405-522-1863
Email: [email protected]
Press Releases and Articles
June 2, 2023
June 1, 2023
OKLAHOMA CITY (June 1, 2023) – As part of an 18-state coalition, Attorney General Gentner Drummond is suing the Biden administration over its proposed new “Circumvention of Lawful Pathways” rule.
May 26, 2023
OKLAHOMA CITY (May 26, 2023) - Attorney General Gentner Drummond lauded the U.S. Supreme Court’s 5-4 ruling yesterday in Sackett v. EPA, a decision that limits the authority of the Environmental Protection Agency.
At issue was the EPA’s Waters of the United States (WOTUS) rule that had been opposed by Oklahoma and other states.
May 26, 2023
OKLAHOMA CITY (May 26, 2023) – Attorney General Gentner Drummond has joined an amicus brief led by Virginia Attorney General Jason Miyares in the case of Florida v. Mayorkas, supporting the State of Florida’s lawsuit against the Biden Administration’s unlawful immigration policy that is creating a dangerous crisis on our southern border. Rather than detaining illegal immigrants as the law requires, the Biden Administration has released those cited at the border into the U.S.
May 24, 2023
OKLAHOMA CITY (May 23, 2023) - Attorney General Gentner Drummond and 48 other U.S. attorneys general filed a lawsuit today against Avid Telecom, its owner and its vice president for allegedly facilitating billions of illegal robocalls and violating the Telephone Consumer Protection Act, the Telemarketing Sales Rule, and other federal and state telemarketing and consumer laws.
May 5, 2023
OKLAHOMA CITY (May 5, 2023) – Attorney General Gentner Drummond made the following remarks today after the U.S. Supreme Court granted a stay of execution for death row inmate Richard Glossip:
“I am very grateful to the U.S. Supreme Court for their decision to grant a stay of execution. I will continue working to ensure justice prevails in this important case.”
May 4, 2023
OKLAHOMA CITY (May 4, 2023) – Attorney General Gentner Drummond today announced that consumers who were tricked by TurboTax’s owner Intuit into paying for free tax services will begin receiving checks from a $141 million multistate settlement announced in May 2022. Approximately 4.4 million consumers nationwide will receive checks in the mail from the multistate settlement. Oklahoma will receive more than $1.7 million for more than 56,000 people who were tricked into paying to file their federal tax return. Eligible consumers will be contacted by email about the settlement.
May 2, 2023
OKLAHOMA CITY (May 2, 2023) – Attorney General Gentner Drummond commended Gov. Stitt for signing legislation today that will help law enforcement crack down on Oklahoma’s rash of illegal marijuana grow operations. Authored by Rep. Jon Echols and Sen. Lonnie Paxton, House Bill 2095 gives the Office of the Attorney General, the Oklahoma Bureau of Narcotics and Dangerous Drugs Control, and the Oklahoma State Bureau of Investigation full enforcement authority over the state’s medical marijuana laws.
May 1, 2023
OKLAHOMA CITY (May 1, 2023) – Attorney General Gentner Drummond, Virginia Attorney General Jason Miyares and a bipartisan coalition of 32 other attorneys general are asking the Supreme Court of the United States (SCOTUS) to hear the case of James Rudisill in Rudisill v. McDonough and protect veterans’ rights.
May 1, 2023
OKLAHOMA CITY (May 1, 2023) – Attorney General Gentner Drummond is leading a coalition of 26 attorneys general in urging the Centers for Medicare and Medicaid Services (CMS) to provide coverage for a drug approved by the U.S. Food and Drug Administration (FDA) that has been proven to delay the progression of Alzheimer’s Disease.
In an April 26 letter, Drummond asked CMS to provide full and unrestricted Medicare coverage for FDA-approved Alzheimer’s treatments, consistent with its decades-long practice of covering FDA-approved prescription drugs for Medicare beneficiaries.